Your browser doesn't support javascript.
loading
Publisher Correction: A clonal expression biomarker associates with lung cancer mortality.
Biswas, Dhruva; Birkbak, Nicolai J; Rosenthal, Rachel; Hiley, Crispin T; Lim, Emilia L; Papp, Krisztian; Boeing, Stefan; Krzystanek, Marcin; Djureinovic, Dijana; La Fleur, Linnea; Greco, Maria; Döme, Balázs; Fillinger, János; Brunnström, Hans; Wu, Yin; Moore, David A; Skrzypski, Marcin; Abbosh, Christopher; Litchfield, Kevin; Al Bakir, Maise; Watkins, Thomas B K; Veeriah, Selvaraju; Wilson, Gareth A; Jamal-Hanjani, Mariam; Moldvay, Judit; Botling, Johan; Chinnaiyan, Arul M; Micke, Patrick; Hackshaw, Allan; Bartek, Jiri; Csabai, Istvan; Szallasi, Zoltan; Herrero, Javier; McGranahan, Nicholas; Swanton, Charles.
Affiliation
  • Biswas D; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
  • Birkbak NJ; Bill Lyons Informatics Centre, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
  • Rosenthal R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Hiley CT; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK. nbirkbak@clin.au.dk.
  • Lim EL; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. nbirkbak@clin.au.dk.
  • Papp K; Department of Molecular Medicine, Aarhus University, Aarhus, Denmark. nbirkbak@clin.au.dk.
  • Boeing S; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark. nbirkbak@clin.au.dk.
  • Krzystanek M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
  • Djureinovic D; Bill Lyons Informatics Centre, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
  • La Fleur L; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Greco M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
  • Döme B; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Fillinger J; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
  • Brunnström H; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Wu Y; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Budapest, Hungary.
  • Moore DA; Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK.
  • Skrzypski M; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Abbosh C; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Litchfield K; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Al Bakir M; Genomics Equipment Park, The Francis Crick Institute, London, UK.
  • Watkins TBK; Department of Tumor Biology, National Korányi Institute of Pulmonology, Semmelweis University, Budapest, Hungary.
  • Veeriah S; Division of Thoracic Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Wilson GA; Department of Thoracic Surgery, National Institute of Oncology, Semmelweis University, Budapest, Hungary.
  • Jamal-Hanjani M; Department of Pathology, National Korányi Institute of Pulmonology, Semmelweis University, Budapest, Hungary.
  • Moldvay J; Department of Pathology, National Institute of Oncology, Budapest, Hungary.
  • Botling J; Lund University, Laboratory Medicine Region Skåne, Department of Clinical Sciences Lund, Pathology, Lund, Sweden.
  • Chinnaiyan AM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
  • Micke P; Department of Pathology, UCL Cancer Institute, London, UK.
  • Hackshaw A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
  • Bartek J; Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
  • Csabai I; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
  • Szallasi Z; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Herrero J; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • McGranahan N; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
Nat Med ; 26(7): 1148, 2020 Jul.
Article in En | MEDLINE | ID: mdl-32494065
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2020 Type: Article